Trial intelligence / Profile preview

Synergies between WS 1070 and structured stress management in patients with asthenia and decreased concentration capacity

DRKS00000692Phase 4Completed

Sponsor
Schwabe Group
Start
Jan 2011
Countries
1
01

Overview

A Phase 4 trial of WS 1070 in asthenia, cognitive disorder (CD), trauma and stressor-related disorders, sponsored by Schwabe Group. Started Jan 2011; status: completed.

02

Drugs

WS 1070
03

Conditions

astheniacognitive disorder (CD)trauma and stressor-related disorders

Beyond the preview

Go deeper on DRKS00000692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call